+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin therapy is associated with improved survival after endovascular and open aneurysm repair



Statin therapy is associated with improved survival after endovascular and open aneurysm repair



Journal of Vascular Surgery 59(1): 39-44.E1



The relationship between numerous risk factors and perioperative mortality after cardiovascular surgery has been studied extensively. While improved perioperative survival and fewer cardiovascular events have been related to statin therapy, its effect on long-term survival after aneurysm repair remains to be elucidated. The aim of this study is to determine the effect of statin therapy on long-term survival after open and endovascular aneurysm repair and to identify other cardiovascular and patient-related risk factors in this respect. A post-hoc analysis of a randomized trial comparing open and endovascular abdominal aortic aneurysm repair was performed. In this multicenter trial, 351 patients were randomly assigned to undergo either open abdominal aortic aneurysm repair or endovascular repair. Patients who were on lipid-lowering medication at their inclusion in the trial (n = 135) were compared with those who were not (n = 216). During 6 years of follow-up, 118 (33.6%) patients died after randomization. Statin therapy, baseline characteristics, Society for Vascular Surgery/International Society for Cardiovascular Surgery risk factors, aneurysm size, reinterventions, antiplatelet or anticoagulant agents, and β-blockers were used to identify prognostic factors influencing survival. After identification of significant factors in a Kaplan-Meier analysis, a multivariable Cox regression analysis was applied. Statin therapy at inclusion in the trial was independently associated with better overall survival after open or endovascular aneurysm repair (hazard ratio [HR], 0.5; 95% confidence interval [CI], 0.3-0.8; P = .004). Statins were especially associated with fewer cardiovascular deaths (HR, 0.4; 95% CI, 0.2-0.9; P = .025). Several risk factors were associated with poor survival after open and endovascular aneurysm repair: age >70 (HR, 3.4; 95% CI, 2.2-5.0; P < .001), a history of cardiac disease at baseline (HR, 1.9; 95% CI, 1.3-2.8; P = .001), and moderate/severe tobacco use (HR, 1.7; 95% CI, 1.2-2.5; P = .004). Gender, aneurysm size, the need for reintervention, pulmonary disease, renal disease, carotid disease, hypertension, diabetes mellitus, antiplatelet or anticoagulant agents, and β-blockers were not significantly associated with impaired long-term survival (P > .05). Despite the limitations of a post-hoc analysis of a prospectively maintained trial, we conclude that statin therapy at the beginning of the trial is independently associated with improved long-term survival after open or endovascular aneurysm repair, while age above 70 years, a history of cardiovascular disease, and tobacco use are associated with decreased long-term survival.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911283

Download citation: RISBibTeXText

PMID: 24144736

DOI: 10.1016/j.jvs.2013.07.026


Related references

The impact of preoperative statin therapy on open and endovascular abdominal aortic aneurysm repair outcomes. Vascular 23(4): 344-349, 2016

Improved survival after abdominal aortic aneurysm rupture by offering both open and endovascular repair. Archives of Surgery 143(6): 544-9; Discussion 550, 2008

Patients with abdominal aortic aneurysm and chronic obstructive pulmonary disease have improved outcomes with endovascular aneurysm repair compared with open repair. Vascular 17(6): 316-324, 2010

Bronchoscopic Lung Volume Reduction: A 2018 Review and Update. Turkish Thoracic Journal 19(3): 141-149, 2018

Comparable mid-term survival in patients undergoing elective fenestrated endovascular aneurysm repair and endovascular aneurysm repair for abdominal aortic aneurysm. Sage Open Medicine 2(): 2050312113519986-2050312113519986, 2014

Statin therapy is associated with aneurysm sac regression after endovascular aortic repair. Journal of Vascular Surgery 55(6): 1587-1592, 2012

Influence of Statin Therapy on Aneurysm Sac Regression after Endovascular Aortic Repair. Journal of Vascular and Interventional Radiology, 2016

Endovascular repair of ruptured abdominal aortic aneurysm does not confer survival benefits over open repair. Journal of Vascular Surgery 56(3): 614-619, 2012

Statin use is associated with improved overall survival without affecting patency and limb salvage rates following open or endovascular revascularization. Vascular Medicine 19(2): 86-93, 2014

Endovascular repair for ruptured abdominal aortic aneurysm confers an early survival benefit over open repair. Journal of Vascular Surgery 58(4): 1091-1105, 2013

Ruptured abdominal aortic aneurysm: endovascular repair does not confer any long-term survival advantage over open repair. Vascular 15(4): 191-196, 2007

External validation of the Endovascular aneurysm repair Risk Assessment model in predicting survival, reinterventions, and endoleaks after endovascular aneurysm repair. Journal of Vascular Surgery 59(6): 1555-61, 1561.E1-3, 2014

Endovascular repair of abdominal aortic aneurysm does not improve early survival versus open repair in patients younger than 60 years. European Journal of Vascular and Endovascular Surgery 43(5): 506-512, 2012

Base-Free Iron Hydrosilylene Complexes via an α-Hydride Migration that Induces Spin Pairing. Journal of the American Chemical Society: -, 2018